SCHEMBL21274980

SCHEMBL21274980

CC(C)(C)OC(=O)N1[C@@H](CCCC#N)CCC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 3/20 0.38
▸ SPHK1 Q9NYA1 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CTSS P25774 2/20 0.32
▸ JAK1 P23458 4/20 0.32
▸ JAK2 O60674 3/20 0.32
▸ CHRM2 P08172 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ DDB1 Q16531 1/20 0.31
▸ CRBN Q96SW2 1/20 0.31
▸ GPR119 Q8TDV5 2/20 0.30
▸ PDE4A P27815 1/20 0.30
▸ PDE4B Q07343 1/20 0.30
▸ PDE4C Q08493 1/20 0.30
▸ PDE4D Q08499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21244946 1.00 CTSK (0.38) CTSKSPHK1MEN1ALDH1A1MAPT
SCHEMBL21288270 0.84 SPHK1 (0.42) CTSKSPHK1MEN1ALDH1A1KMT2A
SCHEMBL21274866 0.84 CTSK (0.41) CTSKSPHK1MEN1ALDH1A1MAPT
SCHEMBL21244565 0.84 CTSK (0.41) CTSKSPHK1MEN1ALDH1A1MAPT
SCHEMBL21244705 0.84 SPHK1 (0.35) CTSKSPHK1MAPTCHRM2CHRM1
SCHEMBL21274752 0.84 SPHK1 (0.35) CTSKSPHK1MAPTCHRM2CHRM1
SCHEMBL21245137 0.83 SPHK1 (0.34) CTSKSPHK1CHRM2CHRM1CHRM3
SCHEMBL21275014 0.83 SPHK1 (0.34) CTSKSPHK1CHRM2CHRM1CHRM3
SCHEMBL21244975 0.82 SPHK1 (0.34) CTSKSPHK1CHRM2CHRM1CHRM3
SCHEMBL21274727 0.82 SPHK1 (0.34) CTSKSPHK1CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752510-A1 MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM Vertex Pharmaceuticals Incorporated (US) 2020-12-23 — — EP disclosed
WO-2019161078-A1 MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-08-22 — — WO disclosed
Send feedback